products
molecules-jppi
jppi-line
ACTIVE PHARMA INGREDIENTS
THERAPEUTIC USE DMF STATUS CAS NO.
   
   
Alendronate Sodium BP Osteoporosis A 121268-17-5
Etidronate Disodium USP Osteoporosis UP 7414-83-7
Ibandronate Sodium Osteoporosis UP 138926-19-9
Pamidronate Disodium Osteoporosis UP 57248-88-1
Risedronate Sodium Osteoporosis UP 115436-72-1
Fosphenytoin Sodium USP Anti Epileptic UP 92134-98-0
Gabapentin Anti Epileptic UP 60412-96-3
Phenytoin Base BP Anti Epileptic A 57-41-0
Phenytoin Sodium BP / EP Anti Epileptic A 630-93-3
Etoricoxib Anti Inflammatory UP 202409-33-4
Bisacodyl BP/USP Laxative UP 603-50-9
Picosulfate Sodium BP/USP Laxative UP 10040-45-6
Eosin Disodium FRP Colours A 17372-87-1
Fluorescein Sodium USP / EP Colours UP 518-47-8
Methylene Blue EP / USP Colours UP 61-73-4
Silver Sulphadiazine USP Infected Burns A 22199-08-2
Tizanidine HCl USP Muscle Relaxant A 64461-82-1
Trimetazidine HCl JP Cardio-Vascular A 13171-25-0
Amlodipin Besylate Cardio-Vascular UP 88150-42-9
Pioglitazone HCl (In House) Anti – Diabetic UP 112529-15-4
Propyl Gallate BP/EP Anti-Oxidant A 121-79-9
A - Available
UP - Under Preparation
INTERMEDIATES
END USE CAS NO.
   
 
4 Aminobutyric Acid Alendronate Sodium 56-12-2
Alendronic Acid Alendronate Sodium 66376-36-1
Ibandronic Acid Ibandronate Sodium 114084-78-5
3-(N-methylpenthylamino)propionic acid HCl Ibandronate Sodium 625120-81-2
Risedronic Acid Risedronate Sodium 105462-24-6
Fluorescein Acid Intermediate 1461-15-0
Janus Green B Electro Plating 2869-83-2
Benzoin Intermediate 119-53-9
Benzil Intermediate 134-81-6
Benzilic Acid Intermediate 76-93-7
Caproic Anhydride (Hexanoic Anhydride) Caproate Derivatives 2051-49-2
Enanthic Anhydride (Heptanoic Anhydride) Enanthate Derivatives 626-27-7
Gallic Acid Gallate Derivative 149-91-7
Pyrogallol Intermediate 87-66-1
2,3,4-Trimethoxy Benzaldehyde Trimetazidine 2103-57-3
5 Chloro 4 Amino – 2,1,3,benzothiadiazole Tizanidine 115398-34-0
Ethylene Urea Tizanidine 120-93-4
Acetyl Ethylene Urea Tizanidine 5391-39-9
4 Bromoaniline Intermediate 106-40-1
Potassium Hydroxide (Powder) Intermediate 1310-58-3
Silver Nitrate Silver Derivatives 7761-88-8
 
None of the products will be supplied to countries in which, it could be in conflict with the existing patent.
However the responsibility lies with a buyer.
 
ACTIVE PHARMA INGREDEINTS SPECIFICATION || PHARMA INTERMEDIATES SPECIFICATION 
Home || company profile ||  our products ||  quality policy ||  enquiry form